Panel Discussion: Harnessing the Strength of Diversity in Clinical Trials
Jessica McDermott
Associate Professor, University of Colorado Cancer Center
This panel on diversity in clinical trials explored the vital role that diverse populations play in advancing medical research and improving health outcomes. Experts discussed the benefits of diverse trials, such as improved drug efficacy across different populations and better safety profiles alongside strategies for overcoming barriers to participation, ensuring inclusive recruitment practices, and fostering trust within underrepresented communities. The session highlighted real-world examples and provided actionable steps to make clinical trials more equitable and representative.
Jessica McDermott, MD is a an associate professor at the University of Colorado Cancer Center and Rocky Mountain Regional VAMC. She has a clinical and research focus on head and neck cancer. She also has been appointed the Deputy AD for Diversity and Inclusion in Clinical Research where she lead efforts to improve patient awareness and recruitment into cancer research and serves as the Director of the Champions of Equity and Engagement in Research at SWOG.